Clinical Trial Update: Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib

View source ↗

Summary

A ClinicalTrials.gov listing notes a retrospective analysis of patients with metastatic renal cell carcinoma treated with CABOzantinib, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: Metastatic Renal Cell Carcinoma | Status: RECRUITING